Good Morning Mamas!
Today I’m encouraging you, Mamas on Bedrest, to get into the holiday spirit! Mamas let your creativity flow-Let your “freak” fly! Celebrate Halloween in a new and creative way on bed rest!
Mamas, I know this isn’t what you wanted. No one actually WANTS bed rest. But it doesn’t mean that you can’t enjoy life and it’s simple pleasures. To that end, we’re having a Halloween Spooktacular! Mamas, share how you are creatively enjoying and participating in Halloween this year. Are you decorating your surroundings? Semd us a photo! Did you paint your belly? Dress up? Bake something amazing (or have one of your recipes baked for you!!), write a poem or create a piece of artwork? Share your creation with our community and inspire other mamas! Submit your creations to firstname.lastname@example.org. The submissions will be posted next week, November 3rd, and as a community, we’ll choose a winner who will receive a $25 Amazon.com gift card. The winner will be announced on November 10th. Happy Halloween Mamas!!
Researchers at the Center for Perinatal Research at the Nationwide Children’s Hospital in Ohio have identified a Urine test that detects proteins in pregnant mamas’ urine that indicate pre-eclampsia. Pre-Eclampsia is one of the most common reasons mamas are prescribed bed rest, and one of the leading causes of preterm labor, prematurity and even death in mamas globally. This new finding is significant because this current research shows that pre-eclampsia, more specifically the proteins found in the urine of pregnant women with pre-eclampsia, are also associated with diseases of neurodegenerative diseases of aging such as Parkinson’s Disease, Mad Cow Disease and Alzheimers Disease.
Dr. Irina Buhimschi, director of the Center for Perinatal Research at Nationwide Children’s Hospital in Ohio and lead author of the paper. While Dr. Buhimschi admits that this is definitely a huge breakthrough in pre-eclampsia research, she admits that physicians and researchers are still no closer to knowing why some women develop pre-eclampsia and why others don’t. Pre-eclampsia is still responsible for some 75,000 deaths annually, mostly in poorer, developing nations. The proteins noted in mamas’ urine are now easily identified with a simple and inexpensive urine test called the Congo Red Dot Test. This simple test merely requires that clinicians place a small amount of urine on a test paper and if a large red dot develops, they know that the urine contains proteins indicative of pre-eclampsia.While we have reported on the Congo Red Dot test previously, a simple test like the Congo Red Dot test could really be a breakthough in treatment in these areas and significantly lower maternal mortality.
Pre-Eclampsia is diagnosed when a mama has high blood pressure and protein in the urine. Mamas will also often experience facial and extremity swelling. Left untreated, pre-eclampsia leads to dizziness, visual changes, seizures, stroke, swelling and weight gain, organ (kidney) failure and death. Pre-Eclampsia is a leading cause of preterm delivery, yet once the baby and placenta are delivered, mama’s symptoms resolve.
The connection between pre-eclampsia and other neurodegenerative diseases such as Alzheimers has yet to be determined. Additionally, no one yet knows if women who develop pre-eclampsia are at greater risk for developing Alzheimers or Parkinson’s Diseases or have some sort of protection. These questions will definitely have to be answered in subsequent research. In the meantime, having a low technology, easy to perform and inexpensive test to screen for pre-eclampsia may well reduce the maternal mortality associated with it tremendously worldwide. Even here in the US, this low lost, low tech test, performed early, may enable obstetricians to begin treating women early with antihypertensive medications and ward off the more serious signs and symptoms of pre-eclampsia. The next step-or perhaps leap-is that perhaps them mamas who have pre-eclampsia may not need to be placed on bed rest-so long as their blood pressures are stabilized on medications, they are no longer spilling proteins into their urine and they are not having any signs of seizure, stroke or organ failure. Finally, combining these findings with the Pluristem Technology, and yes, we may in fact be on the way to eradicating pre-eclampsia!!
Reference: MacLean’s Digital Magazine
If you like information like this, sign up to receive our blog. It’s easy to do, simply click the small orange circle in the upper right hand corner of this page. For other questions, e-mail email@example.com or join the conversation on our Facebook Page.
We all know that “Breast is Best”! Yet in this country, many women are still unaware of the benefits of breastfeeding. Nowhere is this more evident than in the Black community where the US Centers for Disease Control and Prevention noted that only 62% of African American mothers initiated breastfeeding as of 2010 data. By 6 months, only 32% of those mothers were still breastfeeding. So while lactation consultants and others will continue to promote breastfeeding citing the benefits to the baby, there is now an equally significant reason to promote breastfeeding in African American Mamas: Breastfeeding likely protects African American women against Estrogen Receptor negative breast cancer.
Estrogen Receptor negative breast cancer is a very aggressive form of breast cancer and African American women are affected at a disproportionately higher rate than white women. While breastfeeding has been shown to reduce the risk of cancer, this has previously only been shown in Estrogen Receptor positive cancers. According to this current study, African American women who have given birth had a 33% higher risk for ER-negative breast cancer than those who had never given birth, and a 37% higher risk for triple-negative breast cancer. However, breast-feeding lowered the risk for both ER-negative and triple-negative disease. Christine Ambrosone, PhD, chair of the Department of Cancer Prevention and Control at the Roswell Park Cancer Institute in Buffalo, New York summarizes the findings this way:
“These data might partially explain why black women are disproportionately affected by ER-negative breast cancer; although they typically have more children than white women, they have a lower prevalence of lactation. In addition, for every age category in the United States, the incidence of triple-negative breast cancer is higher in black women than in non-Hispanic white women.”
Some researchers are skeptical of the findings, stating that it has yet to be determined that pregnancy is causative of Estrogen Receptor Negative Breast Cancer and breastfeeding reduces risk. However, Dr. Ambrose and her colleagues hold firm that their data suggest that pregnancy and childbirth might actually increase the incidence, but that breast-feeding might lower the risk.
Personally, I feel that since such a simple act could have such a significant outcome, it only makes sense to increase awareness and increase the emphasis among African American women to breastfeed. To date, there is no compelling reason for black women NOT to breastfeed. Now, with the known potential benefits to the baby and the ever emerging benefits to black mamas-now a potential protection against an aggressive form of breast cancer-breastfeeding is becoming more of a necessity than ever!
October is Breast Cancer Awareness Month. Mamas, please share this vital information with other (black) mamas you may know who are either on the fence about breastfeeding or who are against breastfeeding. This data is too important not to share! The potential costs are too great and the solution too simple and readily available. Thank you. Let me know how you fared in the comments section below.
Julie R. Palmer, Emma Viscidi, Melissa A. Troester, Chi-Chen Hong, Pepper Schedin, Traci N. Bethea, Elisa V. Bandera, Virginia Borges, Craig McKinnon, Christopher A. Haiman, Kathryn Lunetta, Laurence N. Kolonel, Lynn Rosenberg, Andrew F. Olshan and Christine B. Ambrosone. “Parity, Lactation, and Breast Cancer Subtypes in African American Women: Results from the AMBER Consortium” Journal of the National Cancer institute (2014) 106 (10): dju237